The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Diabetic macular edema: pathogenesis and advances in treatment
Author(s): 
Pages: 86-90
Year: Issue:  1
Journal: Journal of Clinical Ophthalmology

Keyword:  糖尿病黄斑水肿发病机制抗血管内皮生长因子药物治疗;
Abstract: 糖尿病黄斑水肿(DME)是糖尿病患者眼部常见的并发症,是导致糖尿病患者视力损害的主要原因之一.其发病机制推测是视网膜内、外屏障的破坏以及各种炎症因子的作用,其中血管内皮生长因子对DME的发生发展起了至关重要的作用.随着对DME认识的加深,其治疗方法不断进步.目前DME的治疗为在严格控制血糖、血压、血脂等全身危险因素的基础上积极处理眼部并发症,主要有药物、激光光凝和手术治疗三大类.眼内注射抗血管内皮生长因子药物从其发病机制方面治疗DME,在DME的治疗中的地位越来越重要.
Related Articles
loading...